A detailed history of Consolidated Planning Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Consolidated Planning Corp holds 49,595 shares of MRK stock, worth $5.56 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
49,595
Previous 44,640 11.1%
Holding current value
$5.56 Million
Previous $5.89 Million 4.23%
% of portfolio
1.12%
Previous 1.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$123.8 - $132.96 $613,429 - $658,816
4,955 Added 11.1%
49,595 $6.14 Million
Q1 2024

May 02, 2024

BUY
$113.24 - $131.95 $203,152 - $236,718
1,794 Added 4.19%
44,640 $5.89 Million
Q4 2023

Feb 02, 2024

BUY
$100.18 - $109.02 $129,833 - $141,289
1,296 Added 3.12%
42,846 $4.67 Million
Q3 2023

Nov 08, 2023

BUY
$102.95 - $114.33 $213,930 - $237,577
2,078 Added 5.26%
41,550 $4.28 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $259,252 - $282,573
2,387 Added 6.44%
39,472 $4.55 Million
Q1 2023

May 04, 2023

BUY
$102.94 - $114.86 $962,900 - $1.07 Million
9,354 Added 33.73%
37,085 $3.95 Million
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $2.12 Million - $2.71 Million
24,193 Added 683.8%
27,731 $3.08 Million
Q3 2022

Nov 04, 2022

BUY
$84.53 - $94.96 $23,668 - $26,588
280 Added 8.59%
3,538 $305,000
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $45,919 - $52,052
550 Added 20.31%
3,258 $297,000
Q1 2022

May 03, 2022

SELL
$73.51 - $82.4 $147 - $164
-2 Reduced 0.07%
2,708 $222,000
Q3 2021

Nov 17, 2021

SELL
$71.68 - $78.83 $2,508 - $2,759
-35 Reduced 1.28%
2,710 $204,000
Q2 2021

Jul 26, 2021

SELL
$70.31 - $77.77 $11,601 - $12,832
-165 Reduced 5.67%
2,745 $213,000
Q2 2020

Aug 10, 2020

BUY
$70.42 - $80.13 $7,182 - $8,173
102 Added 3.63%
2,910 $225,000
Q1 2020

May 12, 2020

BUY
$63.36 - $87.82 $6,336 - $8,782
100 Added 3.69%
2,808 $216,000
Q4 2019

Apr 29, 2020

BUY
$77.58 - $87.54 $210,086 - $237,058
2,708 New
2,708 $246,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $284B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Consolidated Planning Corp Portfolio

Follow Consolidated Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Planning Corp with notifications on news.